Disulfide Linkage and Structure of Highly Stable Yeast-derived Virus-like Particles of Murine Polyomavirus

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2014 Feb 26

PMID 24567335

Citations 8

Authors

Claudia Simon

Thomas Klose

Sabine Herbst

Bong Gyoon Han

Andrea Sinz

Robert M Glaeser

Milton T Stubbs

Hauke Lilie

Affiliations

Soon will be listed here.

Abstract

VP1 is the major coat protein of murine polyomavirus and forms virus-like particles (VLPs) in vitro. VLPs consist of 72 pentameric VP1 subunits held together by a terminal clamp structure that is further stabilized by disulfide bonds and chelation of calcium ions. Yeast-derived VLPs (yVLPs) assemble intracellularly in vivo during recombinant protein production. These in vivo assembled yVLPs differ in several properties from VLPs assembled in vitro from bacterially produced pentamers. We found several intermolecular disulfide linkages in yVLPs involving 5 of the 6 cysteines of VP1 (Cys(115)-Cys(20), Cys(12)-Cys(20), Cys(16)-Cys(16), Cys(12)/ Cys(16)-Cys(115), and Cys(274)-Cys(274)), indicating a highly coordinated disulfide network within the in vivo assembled particles involving the N-terminal region of VP1. Cryoelectron microscopy revealed structured termini not resolved in the published crystal structure of the bacterially expressed VLP that appear to clamp the pentameric subunits together. These structural features are probably the reason for the observed higher stability of in vivo assembled yVLPs compared with in vitro assembled bacterially expressed VLPs as monitored by increased thermal stability, higher resistance to trypsin cleavage, and a higher activation enthalpy of the disassembly reaction. This high stability is decreased following disassembly of yVLPs and subsequent in vitro reassembly, suggesting a role for cellular components in optimal assembly.

Citing Articles

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.

Srivastava V, Nand K, Ahmad A, Kumar R Vaccines (Basel). 2023; 11(2).

PMID: 36851356 PMC: 9965603. DOI: 10.3390/vaccines11020479.

Artificial Self-assembling Nanocompartment for Organizing Metabolic Pathways in Yeast.

Cheah L, Stark T, Adamson L, Abidin R, Lau Y, Sainsbury F ACS Synth Biol. 2021; 10(12):3251-3263.

PMID: 34591448 PMC: 8689640. DOI: 10.1021/acssynbio.1c00045.

Human polyomaviruses and cancer: an overview.

Prado J, Monezi T, Amorim A, Lino V, Paladino A, Boccardo E Clinics (Sao Paulo). 2018; 73(suppl 1):e558s.

PMID: 30328951 PMC: 6157077. DOI: 10.6061/clinics/2018/e558s.

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery.

Sanchez-Sanchez L, Tapia-Moreno A, Juarez-Moreno K, Patterson D, Cadena-Nava R, Douglas T J Nanobiotechnology. 2015; 13:66.

PMID: 26452461 PMC: 4599659. DOI: 10.1186/s12951-015-0127-z.

Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.

Norkiene M, Stonyte J, Ziogiene D, Mazeike E, Sasnauskas K, Gedvilaite A BMC Biotechnol. 2015; 15:68.

PMID: 26239840 PMC: 4523907. DOI: 10.1186/s12896-015-0187-z.

References

Mannova P, Forstova J . Mouse polyomavirus utilizes recycling endosomes for a traffic pathway independent of COPI vesicle transport. J Virol. 2003; 77(3):1672-81. PMC: 140913. DOI: 10.1128/jvi.77.3.1672-1681.2003. View

Simon C, Schaepe S, Breunig K, Lilie H . Production of polyomavirus-like particles in a Klgal80 knockout strain of the yeast Kluyveromyces lactis. Prep Biochem Biotechnol. 2013; 43(2):217-35. DOI: 10.1080/10826068.2012.750613. View

Chang D, Fung C, Ou W, Chao P, Li S, Wang M . Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J Gen Virol. 1997; 78 ( Pt 6):1435-9. DOI: 10.1099/0022-1317-78-6-1435. View

Liew M, Rajendran A, Middelberg A . Microbial production of virus-like particle vaccine protein at gram-per-litre levels. J Biotechnol. 2010; 150(2):224-31. DOI: 10.1016/j.jbiotec.2010.08.010. View

Ashcroft A, Lago H, Macedo J, Horn W, Stonehouse N, Stockley P . Engineering thermal stability in RNA phage capsids via disulphide bonds. J Nanosci Nanotechnol. 2006; 5(12):2034-41. DOI: 10.1166/jnn.2005.507. View

Stehle T, Harrison S . High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 1997; 16(16):5139-48. PMC: 1170147. DOI: 10.1093/emboj/16.16.5139. View

Li P, Nakanishi A, Tran M, Salazar A, Liddington R, Kasamatsu H . Role of simian virus 40 Vp1 cysteines in virion infectivity. J Virol. 2000; 74(23):11388-93. PMC: 113244. DOI: 10.1128/jvi.74.23.11388-11393.2000. View

Sasnauskas K, Bulavaite A, Hale A, Jin L, Knowles W, Gedvilaite A . Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology. 2003; 45(4-6):308-17. DOI: 10.1159/000067922. View

Jao C, Weidman M, Perez A, Gharakhanian E . Cys9, Cys104 and Cys207 of simian virus 40 Vp1 are essential for inter-pentamer disulfide-linkage and stabilization in cell-free lysates. J Gen Virol. 1999; 80 ( Pt 9):2481-2489. DOI: 10.1099/0022-1317-80-9-2481. View

10.

Palkova Z, Spanielova H, Gottifredi V, Hollanderova D, Forstova J, Amati P . The polyomavirus major capsid protein VP1 interacts with the nuclear matrix regulatory protein YY1. FEBS Lett. 2000; 467(2-3):359-64. DOI: 10.1016/s0014-5793(00)01170-4. View

11.

Inoue T, Tsai B . A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathog. 2011; 7(5):e1002037. PMC: 3093372. DOI: 10.1371/journal.ppat.1002037. View

12.

Schmidt U, Rudolph R, Bohm G . Mechanism of assembly of recombinant murine polyomavirus-like particles. J Virol. 2000; 74(4):1658-62. PMC: 111640. DOI: 10.1128/jvi.74.4.1658-1662.2000. View

13.

Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K . Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell. 2007; 131(3):516-29. DOI: 10.1016/j.cell.2007.09.038. View

14.

Ludtke S, Baldwin P, Chiu W . EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol. 1999; 128(1):82-97. DOI: 10.1006/jsbi.1999.4174. View

15.

Gotze M, Pettelkau J, Schaks S, Bosse K, Ihling C, Krauth F . StavroX--a software for analyzing crosslinked products in protein interaction studies. J Am Soc Mass Spectrom. 2011; 23(1):76-87. DOI: 10.1007/s13361-011-0261-2. View

16.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

17.

Leavitt A, Roberts T, Garcea R . Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. J Biol Chem. 1985; 260(23):12803-9. View

18.

Stehle T, Harrison S . Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure. 1996; 4(2):183-94. DOI: 10.1016/s0969-2126(96)00021-4. View

19.

Chromy L, Pipas J, Garcea R . Chaperone-mediated in vitro assembly of Polyomavirus capsids. Proc Natl Acad Sci U S A. 2003; 100(18):10477-82. PMC: 193586. DOI: 10.1073/pnas.1832245100. View

20.

Sasnauskas K, Buzaite O, Vogel F, Jandrig B, Razanskas R, Staniulis J . Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol Chem. 1999; 380(3):381-6. DOI: 10.1515/BC.1999.050. View